Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Centers for Medicare and Medicaid Services (CMS) said that deal is expected to supersede the prices negotiated under the ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

A deal between President Donald Trump and Novo Nordisk A/S to slash Ozempic and Wegovy prices under a most-favored-nation ...

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...

The new pricing lowers the monthly cost of Ozempic and Wegovy for Medicare patients from $959 to $274. The agreement followed ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...